Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

Por Berge, Guro, Sando, Sigrid B, Rongve, Arvid, Aarsland, Dag, White, Linda R
Publicado em 2014

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

Por Berge, Guro, Sando, Sigrid B., Albrektsen, Grethe, Lauridsen, Camilla, Møller, Ina, Grøntvedt, Gøril R., Bråthen, Geir, White, Linda R.
Publicado no BMC Neurol (2016)

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42

Por Lauridsen, Camilla, Sando, Sigrid B., Møller, Ina, Berge, Guro, Pomary, Precious K., Grøntvedt, Gøril R., Salvesen, Øyvind, Bråthen, Geir, White, Linda R.
Publicado no Front Aging Neurosci (2017)

Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

Por Lauridsen, Camilla, Sando, Sigrid B., Shabnam, Adiba, Møller, Ina, Berge, Guro, Grøntvedt, Gøril R., Bakken, Inger J., Salvesen, Øyvind, Bråthen, Geir, White, Linda R.
Publicado no Front Aging Neurosci (2016)

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

Por Patra, Kalicharan, Soosaipillai, Antoninus, Sando, Sigrid Botne, Lauridsen, Camilla, Berge, Guro, Møller, Ina, Grøntvedt, Gøril Rolfseng, Bråthen, Geir, Begcevic, Ilijana, Moussaud, Simon, Minthon, Lennart, Hansson, Oskar, Diamandis, Eleftherios P., White, Linda R., Nielsen, Henrietta M.
Publicado no Alzheimers Res Ther (2018)